COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.76
+2.90% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
19.51
P/S ratio
1.40x
EPS (TTM)
$1.73
Dividend yield
—
52W range
$27 – $51
Volume
0.6M
Collegium Pharmaceutical Inc (COLL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-16.53M | $-17.95M | $-21.57M | $-75.05M | $-67.02M | $169.39M | $27.78M | $93.94M | $103.56M | $124.23M | $274.75M | $204.98M | $329.32M |
| Capital expenditures | $206000.00 | $8000.00 | $362000.00 | $2.98M | $990000.00 | $24.35M | $6.44M | $373.77M | $1.94M | $1.62M | $461000.00 | $1.65M | $1.74M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $62000.00 | $22000.00 | $2.21M | $5.79M | $7.95M | $13.78M | $16.53M | $21.91M | $24.25M | $22.87M | $27.14M | $32.40M | $41.91M |
| Free cash flow | $-16.74M | $-17.95M | $-21.93M | $-78.03M | $-68.01M | $145.04M | $21.34M | $-279.83M | $101.61M | $122.61M | $274.29M | $203.33M | $327.58M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $24.57M | $24.57M | $736000.00 | — | — | $7.33M | $12.71M | — | $9.10M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $94.06M | $57.53M | $-34.53M | $27.84M | $23.39M | $6.64M | $12.31M | $-12.74M | — | — | — |